Airway vascularity in asthma

Clinical and Experimental Allergy

Volumn 29, Issue 10, 1999, Pages 1295-1297

  Wilson, J W ^a   Stewart, A G ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; VASCULOTROPIN;

AIRWAY; ANGIOGENESIS; ASTHMA; BLOOD VESSEL PERMEABILITY; CHRONIC BRONCHITIS; CONTROLLED STUDY; EDITORIAL; HUMAN; INFLAMMATION; LUNG LAVAGE; PRIORITY JOURNAL;

EID: 0032833486     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00729.x     Document Type: Editorial

References (29)

1. 1 Jeffery P. Structural and inflammatory changes in COPD. A comparison with asthma. Thorax 1998 ; 53: 129 36.
2. 2 Carroll NG, Cooke C, James AL. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med 1997 ; 155: 689 95.
3. 3 Djukanovic R, Wilson JW, Britten KM Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990 ; 142: 863 71.
4. 4 Wilson JW & Li X. Inflammation and cytokines in airway wall remodelling. In: Stewart AG, ed. Airway Wall Remodelling in Asthma. Boca Raton, FL, USA: CRC Press, 1997: 65 110.
5. 5 Stewart AG, Tomlinson PR, Wilson JW. Regulation of airway wall remodeling: prospects for the development of novel antiasthma drugs. Adv Pharmacol 1995 ; 33: 209 53.
6. 6 Widdicombe J. Why are the airways so vascular? Thorax 1993 ; 48: 290 5.
7. 7 Mitzner W, Wagner E, Brown RH. Is asthma a vascular disorder? Chest 1995 ; 107 (Suppl. 3): 97S 102S.
8. 8 Demoly P, Maly FE, Mautino G VEGF levels in asthmatic airways do not correlate with plasma extravasation. Clin Exp Allergy 1999 ; 29: 1390 4.
9. 9 Boesiger J, Tsai M, Maurer M Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E‐dependent upregulation of Fc epsilon receptor I expression. J Exp Med 1998 ; 188: 1135 45.
10. 10 Van de Graaf EA, Out TA, Roos CM, Jansen HM Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 1991 ; 143: 362 8.
11. 11 James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989 ; 139: 242 6.
12. 12 Li X & Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Resp Crit Care Med 1997 ; 156: 229 33.
13. 13 Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993 ; 148: 1220 5.
14. 14 McDonald DM. Neurogenic inflammation in the respiratory tract: actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am Rev Respir Dis 1987 ; 136: S65 72.
15. 15 Brown LF, Detmar M, Claffey K Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 1997 ; 79: 233 69.
16. 16 Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995 ; 146: 1029 39.
17. 17 Horiuchi T & Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony‐stimulating factor and interleukin‐5. Am J Resp Cell Mol Biol 1997 ; 17: 70 7.
18. 18 Ito A, Hirota S, Mizuno H Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol Internat 1995 ; 45: 715 20.
19. 19 Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M. Differential immunolocalisation of VEGF in rat and human adult lung, and in experimental rat lung fibrosis. Light, fluorescence, and electronmicroscopy. Anat Record 1999 ; 254: 61 73.
20. 20 Nauck M, Roth M, Tamm M Induction of vascular endothelial growth factor by platelet‐activating factor and platelet‐derived growth factor is downregulated by corticosteroids. Am J Resp Cell Mol Biol 1997 ; 16: 398 406.
21. 21 Punglia RS, Lu M, Hsu J Regulation of vascular endothelial growth factor expression by insulin‐like growth factor I. Diabetes 1997 ; 46: 1619 26.
22. 22 Ryuto M, Ono M, Izumi H Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP‐1. J Biol Chem 1996 ; 271: 28220 8.
23. 23 Li X & Wilson JW. Fibrogenic cytokines in airway fibrosis. In: Stewart AG, ed. Airway Remodelling in Asthma. Boca Raton, FL, USA: CRC Press, 1997: 111 38.
24. 24 Iruela‐Arispe ML & Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemostasis 1997 ; 78: 672 7.
25. 25 Murohara T, Horowitz JR, Silver M Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998 ; 97: 99 107.
26. 26 Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998 ; 140: 947 59.
27. 27 Soker S, Svahn CM, Neufeld G. Vascular endothelial growth factor is inactivated by binding to alpha 2‐macroglobulin and the binding is inhibited by heparin. J Biol Chem 1993 ; 268: 7685 91.
28. 28 Stewart AG, Tomlinson PR, Wilson JW. Airway wal remodelling in asthma: a novel target for the development of anti‐asthma drugs. Trends Pharmacol Sci 1993 ; 14: 275 9.
29. 29 Wilson JW, Li X, Pain MC. The lack of distensibility of asthmatic airways. Am Rev Respir Dis 1993 ; 148: 806 9.